Trademark: 87901836
Word
NEOVUE
Status
Registered
Status Code
700
Status Date
Tuesday, September 19, 2023
Serial Number
87901836
Registration Number
7169888
Registration Date
Tuesday, September 19, 2023
Mark Type
4000
Filing Date
Tuesday, May 1, 2018
Published for Opposition
Tuesday, February 19, 2019

Trademark Owner History
NeoGenomics Laboratories, Inc. - Original Registrant

Classifications
44 Medical diagnostic testing services in the field of human disease and human medical conditions; medical testing for diagnostic or treatment purposes; providing medical information to others in the field of human disease, human medical conditions, medical diagnostic testing services and medical testing for diagnostic or treatment purposes; providing an Internet website portal featuring medical information in the field of human disease, and human medical conditions, medical diagnostic testing services, medical testing for diagnostic or treatment purposes; providing cloud-based medical information to others in the field of human disease, human medical conditions, medical diagnostic testing services, and medical testing for diagnostic or treatment purposes; medical testing for diagnostic or treatment purposes for the detection of cancer; medical testing for diagnostic or treatment purposes for the detection of genetic information pertaining to human disease; medical diagnostic testing to aid in diagnosis, prognosis and therapy selection; providing information to others in the fields of pathology, medical diagnostic testing and oncology testing, human disease and human medical conditions
42 Providing on-line non-downloadable software for processing images, graphics and text; providing on-line non-downloadable software for medical testing and analysis of medical test results; providing on-line non-downloadable software for enhanced analyzing, researching, and reviewing of medical, scientific, and genetic information, testing and analysis; providing on-line non-downloadable software to acquire, capture, extract, except, analyze, organize, and manage medical testing, biological information, medical tests, medical test data, and medical test results for the processing of test data and for analysis of medical test results; providing on-line non-downloadable software for enhancing the analysis of research, and review of information pertaining to medical, scientific, genetic, testing and analysis, and information and pertaining to testing and analysis; software as a service (SAAS) services for software for processing images, graphics and text; software as a service (SAAS) services for software for enhanced analyzing, researching, and reviewing of medical, scientific, and genetic information, testing and analysis; software as a service (SAAS) services for software to acquire, capture, extract, except, analyze, organize, and manage medical testing, biological information, medical tests, medical test data, and medical test results for the processing of test data and for analysis of medical test results; software as a service (SAAS) services for software for enhancing the analysis of research, and review of information pertaining to medical, scientific, genetic, testing and analysis, and information and pertaining to testing and analysis; genetic mapping for scientific purposes; gene sequencing for scientific purposes; molecular sequencing for scientific purposes; scientific study and analysis in the field of cancer; clinical research, namely, study and testing of cells; medical and scientific research information in the field of gene sequencing, molecular sequencing, cancer study and analysis, clinical study and testing of cells; scientific research in the field of gene sequencing, molecular sequencing, cancer study and analysis, clinical study and testing of cells, and cancer; providing medical research and scientific research information to others in the fields of oncology, pathology and gene sequencing, molecular sequencing, cancer study and analysis, clinical study and testing of cells scientific testing and research services and clinical scientific testing; providing an internet website portal featuring gene sequencing for scientific purposes, molecular sequencing for scientific purposes, cancer study and analysis, clinical study and testing of cells; scientific and medical research information in the fields of scientific testing and research services, medical research services, and clinical scientific testing; providing cloud-based scientific and medical research information to others in the field of scientific testing and research services, medical research services, and clinical scientific testing; providing temporary use of online non-downloadable software for analysis of medical test results; providing temporary use of online non-downloadable software for enhancement of analysis, research, and review of information pertaining to medical, scientific, genetic, testing and analysis, and information and pertaining to such testing and analysis; software as a service (SAAS) services featuring software for analysis of medical test results; providing on-line non-downloadable software for enhancement of analysis, research, and review of information pertaining to medical, scientific, genetic, testing and analysis, and information pertaining to testing and analysis; providing medical research and scientific research information in the field of oncology; genetic testing, rna testing and sequencing for scientific purposes; scientific testing and research services in the field of human disease and human medical conditions; providing medical research services in the field of human disease and human medical conditions; providing clinical scientific testing services and medical research and testing in the field of human disease and human medical conditions; medical laboratory services, namely, clinical laboratory services, and oncology reference laboratory services, providing medical research and scientific research information to others in the field of pathology, diagnostic testing, oncology testing; providing an interactive website featuring information and reports in the field of scientific research in pathology, diagnostic testing, oncology testing; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; medical and scientific research, namely, conducting clinical trials for others; conducting research and clinical trials for others relating to medical devices and pharmaceuticals; medical laboratory services, namely, medical oncology reference laboratory services
NEO VIEW

Trademark Events
Sep 19, 2023
Notice Of Registration Confirmation Emailed
Sep 19, 2023
Registered-Principal Register
Aug 16, 2023
Notice Of Acceptance Of Statement Of Use E-Mailed
Aug 15, 2023
Allowed Principal Register - Sou Accepted
Apr 4, 2023
Teas/Email Correspondence Entered
Apr 3, 2023
Correspondence Received In Law Office
Apr 3, 2023
Teas Response To Office Action Received
Feb 1, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Feb 1, 2023
Teas Change Of Correspondence Received
Feb 1, 2023
Teas Change Of Owner Address Received
Jan 19, 2023
Assigned To Examiner
Nov 10, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Nov 10, 2022
Teas Change Of Correspondence Received
Nov 10, 2022
Teas Change Of Owner Address Received
Oct 3, 2022
Notification Of Non-Final Action E-Mailed
Oct 3, 2022
Non-Final Action E-Mailed
Oct 3, 2022
Su - Non-Final Action - Written
Jul 13, 2022
Assigned To Examiner
Jun 13, 2022
Teas Change Of Correspondence Received
Jun 13, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 13, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 16, 2022
Statement Of Use Processing Complete
Apr 14, 2022
Use Amendment Filed
Apr 14, 2022
Teas Statement Of Use Received
Oct 13, 2021
Notice Of Approval Of Extension Request E-Mailed
Oct 12, 2021
Sou Extension 5 Granted
Oct 6, 2021
Sou Extension 5 Filed
Oct 6, 2021
Sou Teas Extension Received
Apr 16, 2021
Notice Of Approval Of Extension Request E-Mailed
Apr 15, 2021
Sou Extension 4 Granted
Apr 12, 2021
Sou Extension 4 Filed
Apr 12, 2021
Sou Teas Extension Received
Apr 12, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 12, 2021
Teas Change Of Correspondence Received
Apr 12, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 12, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 12, 2021
Teas Change Of Owner Address Received
Oct 15, 2020
Notice Of Approval Of Extension Request E-Mailed
Oct 14, 2020
Sou Extension 3 Granted
Oct 12, 2020
Sou Extension 3 Filed
Oct 12, 2020
Sou Teas Extension Received
Oct 12, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Oct 12, 2020
Teas Change Of Correspondence Received
Oct 12, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 12, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 12, 2020
Teas Change Of Owner Address Received
Apr 4, 2020
Notice Of Approval Of Extension Request E-Mailed
Apr 3, 2020
Sou Extension 2 Granted
Apr 1, 2020
Sou Extension 2 Filed
Apr 3, 2020
Case Assigned To Intent To Use Paralegal
Apr 1, 2020
Sou Teas Extension Received
Apr 1, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 1, 2020
Teas Change Of Correspondence Received
Apr 1, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 1, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 1, 2020
Teas Change Of Owner Address Received
Oct 15, 2019
Notice Of Approval Of Extension Request E-Mailed
Oct 11, 2019
Sou Extension 1 Granted
Oct 11, 2019
Sou Extension 1 Filed
Oct 11, 2019
Sou Teas Extension Received
Jul 3, 2019
Assignment Of Ownership Not Updated Automatically
Apr 16, 2019
Noa E-Mailed - Sou Required From Applicant
Feb 19, 2019
Official Gazette Publication Confirmation E-Mailed
Feb 19, 2019
Published For Opposition
Jan 30, 2019
Notification Of Notice Of Publication E-Mailed
Jan 11, 2019
Approved For Pub - Principal Register
Jan 11, 2019
Examiner's Amendment Entered
Jan 11, 2019
Notification Of Examiners Amendment E-Mailed
Jan 11, 2019
Examiners Amendment E-Mailed
Jan 11, 2019
Examiners Amendment -Written
Dec 10, 2018
Teas/Email Correspondence Entered
Dec 10, 2018
Correspondence Received In Law Office
Dec 10, 2018
Assigned To Lie
Dec 7, 2018
Assigned To Lie
Dec 3, 2018
Teas Response To Office Action Received
Jun 27, 2018
Notification Of Non-Final Action E-Mailed
Jun 27, 2018
Non-Final Action E-Mailed
Jun 27, 2018
Non-Final Action Written
Jun 26, 2018
Assigned To Examiner
May 9, 2018
New Application Office Supplied Data Entered
May 4, 2018
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24